modifibio
@modifibio
Followers
21
Following
1
Media
0
Statuses
6
Modifying DNA to eradicate cancer...
55 Church St, New Haven, CT
Joined May 2024
We look forward to translating this amazing Yale science into the clinic next year, for #gbm patients and beyond 💫.#btsm.#defeatgbm.#benchtobedside. @yalecancer.@yaleventures.@CT_Innovate .@BioCT_org .@ACSBrightEdge .@sontagfdn .@NBTStweets.
This is a labor of love led by the @HerzonLab, which highlights the benefits of creative, cross-disciplinary collaborations in science…excited to drive this into the clinic at light speed 🙏🏽🙌🏽. @YaleRadOnc .@YaleChem .@yalepathology .@YaleCancer .@Yale_Ventures .@modifibio.
0
0
2
Modifi Bio is very excited to bring this class of drugs into the clinic for glioma + many other MGMT-deficient tumors!.@ranjitbindra .@HerzonLab .@LinKingson . #biotech.#startuplife.#DIY. @yaleventures .@CT_Innovate .@BioCT_org .@NBTStweets .@NBTSCSO .@sontagfdn .@ACSBrightEdge.
This is been a truly wonderful collaboration, drawing on the @HerzonLab mastery of synthetic chemistry and our lab's focus of exploiting DDR defects for a therapeutic gain! An entirely new way to treat tumors with DNA modifiers!.@YaleChem .@YaleRadOnc .@YaleCancer .@modifibio.
0
1
2
RT @NaOHBartfield: This stuff is so cool. I am so amazingly lucky to have a front row seat to the cutting edge of cancer therapy!.
0
1
0
Modifi Bio is similarly grateful to have @LinKingson as one of its scientific co-founders! We are excited to translate his work into the brain tumor clinic next summer 👏🤜.
Forever grateful to work with such talented trainees like @LinKingson @ForbesUnder30 @PDSoros @YaleRadOnc @YaleCancer @yalepathology . 🙏🏽👇🏽👏🏽👊🏽. #academia.#science.
0
1
1
Very excited to have Dr. LoRusso on the @modifibio SAB, a true force of nature!.
Spotted! Amazing breakfast with med onc/peds onc zen masters/mentors/friends, Pat LoRusso and @drsam!. #asco2024 . @YaleCancer .@YaleRadOnc .@ASCO . @DayOneBio .@modifibio.@Cybrexa
0
1
1
We are very excited to translate this work into the clinic soon, for patients with MGMT-deficient brain tumors and beyond! #biotech #science #btsm. @yaleventures .@CT_Innovate .@BioCT_org .@Advance_CT .@NBTStweets .@NBTSCSO.
It’s out! Our follow-up study on KL50, a novel DNA modifier that exploits brain tumor DDR defects! Grateful for the opportunity to collaborate w/ the @HerzonLab on this exciting project. @LinKingson @YaleRadOnc @YaleCancer . @Yale_Ventures @modifibio .
0
1
6